Metachronous malignancies after response to checkpoint inhibition

Eur J Cancer. 2022 Oct:174:99-101. doi: 10.1016/j.ejca.2022.07.003. Epub 2022 Aug 17.

Authors

Mirjam A de Visser¹, Francois B Verschaeve², Lot A Devriese³, Bart Neyns², Karijn P M Suijkerbuijk³

Affiliations

¹ Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands. Electronic address: [email protected].
² Department of Medical Oncology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussel, Belgium.
³ Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.

PMID: 35987134
DOI: 10.1016/j.ejca.2022.07.003

No abstract available

Publication types

Letter

MeSH terms

Humans
Neoplasms, Multiple Primary*
Neoplasms, Second Primary* / drug therapy
Neoplasms, Second Primary* / pathology